Critical Care Management for Novel 2019 SARS-CoV-2 and HCoV-NL63 Coinfection in a Young Immunocompromised Patient: A Chicago Experience

<div>TTE showing a free-flowing pericardial effusion identified circumferentially to the heart. Mild decrease of her left ventricular systolic function, from 50% in January 2020 to 40-45%. (a) Parasternal short axis view. (b) Subxiphoid view.</div>

Case Reports in Critical Care

fig2

Figure 2

Figure 2: Critical Care Management for Novel 2019 SARS-CoV-2 and HCoV-NL63 Coinfection in a Young Immunocompromised Patient: A Chicago Experience 